The Global Plasma Protease C1-inhibitor Treatment Market is estimated to be valued at US$ 3,289.5 million in 2020 and is expected to exhibit a CAGR of 18% during the forecast period 2022-2028. The global plasma protease C1 inhibitor therapy market is expected to witness strong growth in the coming years owing to the increase in […]
